Brian Adams
Chief Legal Officer · Kymera Therapeutics, Inc.
IndividualSelling only
- 2024
- Sep 4, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Brian Adams files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BVF PARTNERS L P - $173.67M in KYMR purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $172.50M in KYMR purchases and sales in the last 12 months
- Bruce Booth - $100.59M in KYMR purchases and sales in the last 12 months
- Nello Mainolfi - $36.82M in KYMR purchases and sales in the last 12 months
- Jeremy G. Chadwick - $15.60M in KYMR purchases and sales in the last 12 months
- Bruce N. Jacobs - $9.96M in KYMR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Brian Adams?
Brian Adams is a corporate insider, tracked as Chief Legal Officer of Kymera Therapeutics, Inc. (KYMR). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Brian Adams submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Brian Adams been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($831K) across all tracked filings.
